Mergers and Acquisitions (M&A): Merck (NYSE: MRK) to Complete $9.2 Billion Acquisition of Cidara Therapeutics (NASDAQ: CDTX)
Rahway, New Jersey – Merck has announced the acquisition of Cidara Therapeutics (https://www.cidara.com/). According to the company announcement Merck, known as MSD outside of the United States and Canada, is a premier research-intensive biopharmaceutical company…